We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

16 hedge funds and large institutions have $8.38M invested in Tenax Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

39% less capital invested

Capital invested by funds: $13.6M → $8.38M (-$5.26M)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$322K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$182K
3
BFM
Boothbay Fund Management
New York
+$36K
4
HF
HRT Financial
New York
+$18K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.76K

Top Sellers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
-$54K
2
Renaissance Technologies
Renaissance Technologies
New York
-$31.5K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$4.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
1
Gofen & Glossberg
Illinois
$3.97M – – –
AC
2
Armistice Capital
New York
$2.1M – – –
IC
3
Ikarian Capital
Texas
$722K +$322K +143 +49%
BlackRock
4
BlackRock
New York
$533K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$374K -$4.5K -2 -0.9%
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$208K +$182K +81 +184%
State Street
7
State Street
Massachusetts
$142K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$84K -$31.5K -14 -22%
BFM
9
Boothbay Fund Management
New York
$75K +$36K +16 +55%
FWP
10
FAS Wealth Partners
Kansas
$61K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$53K – – –
Northern Trust
12
Northern Trust
Illinois
$36K – – –
HF
13
HRT Financial
New York
$13K +$18K +8 New
TRCT
14
Tower Research Capital (TRC)
New York
$5K +$6.76K +3 New
UBS Group
15
UBS Group
Switzerland
$5K +$6.76K +3 New
BCV
16
Banque Cantonale Vaudoise
Switzerland
$1K – – –
OCA
17
Octagon Capital Advisors
New York
– -$54K -19 Closed

TENX Hedge Fund Activity: Q4 2021 in Review

16 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2021, worth a combined $8.38M — down 39% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TENX positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Ikarian Capital, adding an estimated $322K. The largest seller was Octagon Capital Advisors, exiting entirely with an estimated $54K sold.

  • 16 institutional investors held Tenax Therapeutics (TENX) as of Q4 2021, up from 14 in Q3 2021.
  • Funds reported $8.38M of Tenax Therapeutics stock for Q4 2021, down 39% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q4 2021 and 1 closed out, a net change of +2 holders.
  • The largest Tenax Therapeutics buyer in Q4 2021 was Ikarian Capital, an estimated $322K added.
  • The largest Tenax Therapeutics seller in Q4 2021 was Octagon Capital Advisors, an estimated $54K sold.

Based on aggregated 13F filings for Q4 2021.